Sofinnova leads €35.5m capital increase for Inventiva
Sofinnova Partners has invested €10m in a €35.5m capital increase for listed life sciences company Inventiva.
The VC firm drew capital from Sofinnova Crossover Fund I, which held a final close on €275m in April 2018, surpassing its €250m target.
The fund was launched with the strategy of targeting later-stage companies and making investments in both private and public markets.
Inventiva will use the fresh capital to advance its clinical programmes, in particular allowing the company's lead compound, lanifbranor, to advance towards phase-III trials.
Company
Inventiva was founded in October 2011 and has been listed on Euronext Paris since February 2017. It is a biopharmaceutical company specialising in the development of treatments for fibrotic and orphan diseases, such as non-alcoholic steato hepatitis (NASH), systemic scleroderma (SSC) and mucopolysaccharidosis (MPS). The company employed 107 people as of December 2017 and generated a loss of €20.4m for the year.
People
Sofinnova Partners – Jacques Theurillat (partner).
More on PIPEs
Gatemore eyes larger stakes in listed SMEs as path to take-privates
With its first closed-end fund in the making, the activist investor will use larger stakes to drive value creation and direct small-cap targets towards PE sales
Allego to go public via merger with Apollo-sponsored Spac
Transaction values Allego at a pro forma equity value of USD 3.14bn, including a USD 150m PIPE
Permira makes EUR 1.9bn investment in Adevinta
Deal will see eBay decrease its stake in Adevinta as part of the acquisition of eBay Classifieds
Apollo makes first deal from Impact strategy
Apollo will launch a take-private bid for the recycled cardboard producer on completion of the deal
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater